British charitable trust that draws on OxyContin-maker fortune says it exempted names to protect reputations ...

(Bloomberg) -- Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the deadly ...

NEW YORK — The Solomon R. Guggenheim Museum in New York said Friday that it did not plan to accept future gifts from the family of Mortimer Sackler, a philanthropist and former board member whose ...

On Monday, the Supreme Court will take on one of its highest-profile bankruptcy cases in recent memory: Whether or not to approve OxyContin-maker Purdue Pharma's controversial agreement that would ...

“Interoffice documents paint a dark picture of profit for the family at the expense of human life,” the artist-activist group P.A.I.N. told Hyperallergic. But a more recent development in the Purdue ...

Mortimer D. Sackler, a psychiatrist and drug executive known for major gifts to the Guggenheim Museum, the Metropolitan Museum of Art, and Columbia University, died last week at his home in ...

Press releases are posted on Independent.com as a free community service. OAKLAND — California Attorney General Rob Bonta today announced that the bipartisan States Negotiating Committee and other ...

Tennessee Attorney General Jonathan Skrmetti on Thursday announced that a bipartisan coalition of states and other parties have reached a $7.4 billion settlement in principle with members of the ...

The Supreme Court on Thursday blew up the massive bankruptcy reorganization of opioid maker Purdue Pharma, finding that the settlement inappropriately included legal protections for the Sackler family ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Bankrupt Purdue Pharma LP and members of the billionaire ...

Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the deadly opioid epidemic ...